Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome  Masaru Nakayama, MD, Ritsuko Katafuchi, MD, Tetsuro Yanase, MD, Kiyoshi Ikeda, MD, Hiroshi Tanaka, MD, Satoru Fujimi, MD  American Journal of Kidney Diseases  Volume 39, Issue 3, Pages 503-512 (March 2002) DOI: 10.1053/ajkd.2002.31400 Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions

Fig. 1 Response rate of adult-onset MCNS to corticosteroid therapy in our study and other reports. (○), Present study (57 patients); (■), Nolasco et al8; (▴), Korbet et al9; (□), International Study of Kidney Disease in Children5; (×), Mak et al12; and (▵), Fujimoto et al.11 American Journal of Kidney Diseases 2002 39, 503-512DOI: (10.1053/ajkd.2002.31400) Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions

Fig. 2 Course of steroid-treated patients who entered complete remission during the first 16 weeks after starting treatment in our study and other reports. (—), Present study (44 patients); (▴), Nolasco et al8; (×), Korbet et al9; and (■), Fujimoto et al.11 American Journal of Kidney Diseases 2002 39, 503-512DOI: (10.1053/ajkd.2002.31400) Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions

Fig. 3 Remission rate after relapse. (●), Twelve patients treated with combination cyclophosphamide therapy after relapses; (○), 10 patients treated with corticosteroids alone after relapses. American Journal of Kidney Diseases 2002 39, 503-512DOI: (10.1053/ajkd.2002.31400) Copyright © 2002 National Kidney Foundation, Inc Terms and Conditions